The observation that TGF-β1 production by B cells restrained proinflammatory T cell activation, and histologic and clinical manifestations of CNS autoimmunity, provides novel insight regarding B-APC cell communication in the pathogenesis of MS and the use of B cell depletion in its therapy. This evidence concerns the gene TGFB1 and myeloid sarcoma.